Back to top

Image: Bigstock

Incyte (INCY) Looks Good: Stock Adds 8.3% in Session

Read MoreHide Full Article

Incyte Corporation (INCY - Free Report) was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $90.81 to $101.91 in the past one-month time frame.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Incyte currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Incyte Corporation Price

Investors interested in the Medical - Biomedical and Genetics industry may consider Akcea Therapeutics, Inc. , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Zacks Top 10 Stocks for 2020

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020? 

Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys. 

Access Zacks Top 10 Stocks for 2020 today >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Incyte Corporation (INCY) - free report >>

Published in